• 4μ8C as a Precision Tool for Decoding ER Stress and Protein

  2026-07-15

  Explore how 4μ8C (7-hydroxy-4-methyl-2-oxochromene-8-carbaldehyde) enables precise dissection of ER stress signaling, linking IRE1α inhibition to advances in ADP-ribosylation research. This article uniquely bridges mechanistic UPR studies and protein degradation pathways for cancer research.

• Eltanexor (KPT-8602): Redefining Nuclear Export in Translati

  2026-07-15

  Eltanexor (KPT-8602) represents a transformative advance in the targeting of nuclear export for cancer therapeutics. This article unpacks the mechanistic rationale, pivotal preclinical data, and strategic imperatives for translational researchers leveraging Eltanexor in hematological and solid tumor models. With a focus on the emerging impact of XPO1 inhibition in pathways such as Wnt/β-catenin signaling and chemoprevention, this piece moves beyond conventional product reviews, providing a forward-looking perspective on how Eltanexor can accelerate discovery and clinical translation.

• Prenatal Esketamine Impairs Neurogenesis: 5-EdU Assay Insigh

  2026-07-14

  A recent study reveals that prenatal exposure to esketamine leads to impaired neurogenesis and neurobehavioral deficits in rat offspring, using 5-Ethynyl-2'-deoxyuridine (5-EdU) labeling to assess proliferative capacity. These findings raise critical considerations for the safety of anesthetic use during pregnancy and highlight advanced cell proliferation assays for neurodevelopmental research.

• 1,2-Dioleoyl-3-trimethylammonium-propane Chloride in Precisi

  2026-07-14

  Explore the unique capabilities of 1,2-Dioleoyl-3-trimethylammonium-propane chloride (DOTAP) for next-generation nucleic acid delivery. This article delivers a deep dive into its mechanism, protocol optimization, and translational applications, offering new insights that extend beyond previous literature.

• CARM1-Targeted Peptide Inhibition Suppresses Breast Cancer P

  2026-07-13

  A novel peptide inhibitor selectively targeting CARM1 was shown to suppress breast cancer cell proliferation and tumor growth both in vitro and in vivo. The findings highlight a promising therapeutic avenue for overcoming endocrine resistance in estrogen receptor-positive breast cancer and offer new mechanistic insights into epigenetic regulation of tumorigenesis.

• Cardamomin Mitigates Oxidative Damage in Ischemic Stroke Mod

  2026-07-13

  This study reveals that cardamomin, a chalcone from Amomum villosum, protects neural tissue from oxidative damage and reduces infarct size in models of cerebral ischemic stroke. The research elucidates specific molecular mechanisms—particularly NRF2 pathway activation and cell death pathway modulation—offering preclinical insights for neuroprotection strategies.

• Schizophrenia GWAS Loci Reveal Divergent Pathways in Neuron

  2026-07-12

  Liu et al. reveal that schizophrenia-associated genetic variants converge on different molecular pathways in developing cortical interneurons versus glutamatergic neurons, using homogeneous human iPSC-derived cell populations. This cell type-specific resolution provides mechanistic insight into how schizophrenia risk genes impact brain development and offers direction for targeted therapeutic research.

• Direct Mouse Genotyping Kit Plus: Precision in Mouse Genotyp

  2026-07-10

  The Direct Mouse Genotyping Kit Plus streamlines mouse genotyping with rapid, purification-free DNA extraction and high-fidelity PCR, ideal for transgene detection and gene knockout validation. Its robust workflow accelerates animal colony genetic screening and delivers reproducible results, even with challenging tissue samples.

• High Viscosity Drives Chemoresistance via P-gp Upregulation

  2026-07-09

  This study reveals that increased extracellular fluid viscosity in the tumor microenvironment induces chemoresistance by upregulating P-glycoprotein (P-gp) expression through a mechanosensitive signaling axis. These findings highlight the biomechanical regulation of drug resistance and suggest that targeting microenvironmental viscosity or P-gp may enhance chemotherapy outcomes.

• PFHxS Disrupts Lipid Metabolism via PPARα Activation in Zebr

  2026-07-09

  This study uncovers how environmentally relevant levels of perfluorohexanesulfonic acid (PFHxS) disrupt lipid homeostasis in zebrafish larvae through targeted activation of PPARα signaling. Integrated lipidomic and transcriptomic approaches reveal molecular pathways affected by PFHxS, highlighting its significance for metabolic disorder research and toxicological risk assessment.

• Technical Use and QC of 0.4% Trypan Blue Solution (K1183)

  2026-07-08

  0.4% Trypan Blue Solution provides a fast, reliable approach for assessing cell viability and live/dead discrimination in research cell culture workflows. It should be used for membrane-integrity–based viability checks, but is not appropriate for clinical diagnostics or for detecting early apoptotic changes. Researchers should follow established QC protocols to ensure accurate, reproducible results.

• Arachidonic Acid: Optimizing Eicosanoid Biosynthesis Assays

  2026-07-08

  Arachidonic acid unlocks precise control in inflammation and immune cell assays, bridging basic lipid signaling models to translational vaccine research. Its solubility profile, bioactivity, and validated impact on humoral immunity make it indispensable for advanced eicosanoid biosynthesis workflows.

• Gap26 Connexin 43 Mimetic Peptide: Advanced Insights in Infl

  2026-07-07

  Explore the scientific depth of Gap26, a connexin 43 mimetic peptide, in modulating inflammation and vascular signaling. This article uniquely analyzes mechanistic findings and assay decision-making, offering advanced context beyond existing resources.

• CCK-8 Ammonium Induces ANP Secretion via NOX4–PGC-1α–PPAR Pa

  2026-07-07

  This study demonstrates how sulfated cholecystokinin octapeptide (CCK-8 ammonium) directly stimulates atrial natriuretic peptide (ANP) secretion in isolated rat atria via a defined NOX4–PGC-1α–PPARα/PPARγ signaling axis. The findings clarify the cardiac signaling mechanisms of CCK-8 and suggest new avenues for investigating peptide-mediated regulation of cardiovascular function.

• ZCL278: Selective Cdc42 Inhibitor for Cell Motility and Fibr

  2026-07-06

  ZCL278 empowers targeted dissection of the Cdc42 signaling pathway, enabling researchers to modulate cell motility, neuronal branching, and fibrotic responses with unprecedented precision. This guide delivers actionable protocols, advanced troubleshooting, and translational insights, positioning ZCL278 as a uniquely versatile tool for mechanistic and disease modeling studies.

446 records 11/30 page Previous Next First page 上5页 1112131415 下5页 Last page